matrix-assisted laser desorption/ionization time of flight mass spectrometry

OTHER10 trials

Sponsors

SWOG Cancer Research Network, National Cancer Institute (NCI), Charing Cross Hospital, City of Hope Medical Center, Vanderbilt-Ingram Cancer Center

Conditions

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Breast CancerHead and Neck Cancer

Phase 1

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

CompletedNCT00645710

City of Hope Medical CenterLiver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer +2

Start: 2005-02-11End: 2018-02-07Updated: 2019-03-28

Phase 2

Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

CompletedNCT00492401

National Cancer Institute (NCI)Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) +5

Start: 2007-05-31End: 2014-10-31Updated: 2016-06-27

Phase 3

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

Charing Cross HospitalBreast Cancer

Start: 2007-01-31Target: 1000Updated: 2013-08-07

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Istituto Scientifico H. San RaffaeleLung Cancer

Start: 2008-02-29Target: 275Updated: 2013-08-12

Unknown Phase

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

CompletedNCT00450281

SWOG Cancer Research NetworkLung Cancer

Start: 2005-10-31End: 2012-07-31Updated: 2015-10-26

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

RecruitingNCT00897117

Vanderbilt-Ingram Cancer CenterLung Cancer

Start: 2001-05-31End: 2031-05-31Target: 4000Updated: 2025-09-26

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

CompletedNCT00899028

Vanderbilt University Medical CenterLung Cancer

Start: 2001-05-31End: 2016-08-31Updated: 2017-04-20

Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer

CompletedNCT00898911

ECOG-ACRIN Cancer Research GroupHead and Neck Cancer

Start: 2008-07-08End: 2012-04-08Updated: 2017-05-17

Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab

CompletedNCT00898417

ECOG-ACRIN Cancer Research GroupLung Cancer

Start: 2008-03-14End: 2008-04-14Updated: 2017-05-19

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

TerminatedNCT00991991

Case Comprehensive Cancer CenterMelanoma (Skin)

Start: 2009-07-31End: 2016-03-31Updated: 2016-05-17

Related Papers

Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance.

2023-11-203 citations

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.

2014-05-13128 citations

Randomized proteomic stratified phase III study of second-line erlotinib (E) versus chemotherapy (CT) in patients with inoperable non-small cell lung cancer (PROSE).

Journal of Clinical Oncology2013-06-2014 citations